Allergisa is a renowned Brazilian research institution dedicated to providing comprehensive safety and efficacy testing services for the cosmetic, personal care, pharmaceutical, and household product industries. Founded in 1993 and headquartered in Campinas, São Paulo, Allergisa operates state-of-the-art laboratories and employs a team of experienced scientists. The company conducts a wide array of in vitro and clinical studies, adhering to rigorous international quality standards, including ISO 9001 and Good Clinical Practices (GCP) certified by ANVISA. Allergisa is committed to scientific excellence, ethical research, and innovation, supporting companies globally in product development, claim substantiation, and regulatory compliance.
The Campinas facility is Allergisa's core hub for all research and testing operations. This includes clinical trials with human volunteers, diverse in vitro safety and efficacy studies, laboratory analysis, quality assurance processes, and corporate administration.
The headquarters boasts advanced, specialized laboratories for dermatological, cosmetic, ophthalmic, pediatric, and gynecological testing. It includes dedicated clinical trial units, cell culture labs, and areas for microbiological and photochemical studies, all designed to meet stringent regulatory standards.
Allergisa fosters a work culture centered on scientific integrity, meticulous precision, continuous learning, and interdisciplinary collaboration. There's a strong emphasis on ethical conduct in research, robust quality management systems (like ISO 9001 and GCP), and staying at the forefront of scientific advancements in product testing methodologies.
This centralized headquarters is crucial for Allergisa as it houses all critical operational units, enabling seamless integration and efficient execution of complex testing protocols. Its location within São Paulo state facilitates collaboration with other research institutions, universities, and industry partners, fostering innovation and access to a skilled talent pool.
While Allergisa's physical laboratories and headquarters are located in Brazil, the company serves a diverse clientele that includes both national and international corporations. They provide testing services for companies looking to market their products in Brazil, requiring compliance with ANVISA regulations, as well as for entities needing studies that adhere to internationally recognized standards (e.g., OECD, ISO, FDA guidelines). Allergisa supports global product development and launch strategies by offering robust safety and efficacy evaluations. They actively participate in international scientific congresses and maintain collaborations that keep them aligned with global best practices in dermatological, cosmetic, and pharmaceutical testing.
Av. Charles Goodyear, 100 - Distrito Industrial
Campinas
São Paulo
Brazil
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Allergisa' leadership includes:
Allergisa has been backed by several prominent investors over the years, including:
Based on publicly available information, there have been no major high-profile executive hires or departures announced by Allergisa in the last 12 months. The company appears to maintain a stable leadership team focused on its core mission of scientific research and product testing.
Discover the tools Allergisa uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Allergisa likely employs common corporate email formats. These typically involve combinations of an employee's first name, last name, or initials, followed by the '@allergisa.com.br' domain. For general inquiries, they also have departmental or contact-specific email addresses.
[first].[last]@allergisa.com.br or [first_initial][last]@allergisa.com.br
Format
sguerra@allergisa.com.br (example for Samuel Guerra if using [first_initial][last])
Example
80%
Success rate
Allergisa Official Website / ANVISA • August 15, 2023
Allergisa has been awarded the Good Clinical Practices (Boas Práticas Clínicas - BPC) certification by ANVISA (Brazilian Health Regulatory Agency). This significant certification underscores Allergisa's adherence to high quality and ethical standards in conducting clinical research for health products, reinforcing its credibility and commitment to excellence....more
Cosmetic Innovation • June 6, 2023
Allergisa announced strategic investments in new technologies aimed at broadening its capabilities for testing cosmetic products, with a particular focus on their interactions with the skin microbiota. This initiative responds to the growing industry demand for more sophisticated and detailed assessments of product safety and efficacy concerning the skin's microbiome....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Allergisa, are just a search away.